Publications by authors named "G S Levy"
Background: Individuals identifying as Black, American Indian or Alaska Native, or Hispanic or Latino lack access to culturally appropriate accurate information and are the target of disinformation campaigns, which create doubt in science and health care providers and might play a role in sustaining health disparities related to the COVID-19 pandemic.
Objective: This study aims to create and disseminate culturally and medically appropriate social media messages for Black, Latino, and American Indian or Alaska Native communities in Wisconsin and evaluate their reach and effectiveness in addressing the information needs of these communities.
Methods: Our team identified relevant COVID-19 topics based on feedback from their respective community, developed lay format materials, and translated materials into culturally appropriate social media messages that community advocates delivered across their respective communities.
Article Synopsis
- The incorporation of fluorinated amino acids into proteins allows for better understanding of biomolecular structures and functions.
- A new method for site-specific integration of fluoroprolines into proteins has been developed, tested on a non-pathogenic version of the huntingtin protein.
- Experimental findings reveal that the effects of fluoroproline variants on protein structure vary based on factors like stereochemistry and the specific amino acid sequence, with insights supported by molecular dynamics simulations.
Study Objective: To evaluate clinical efficacy of office operative hysteroscopic treatment of retained products of conception (RPOC) without anesthesia.
Design: A retrospective cohort study.
Setting: A tertiary care academic medical center between April 2019 to March 2023.
Efficacy and safety of upadacitinib versus dupilumab in adults and adolescents with moderate-to-severe atopic dermatitis: week 16 results of an open-label randomized efficacy assessor-blinded head-to-head phase IIIb/IV study (Level Up).
Br J Dermatol
December 2024
Article Synopsis
- * The study compared the effectiveness and safety of upadacitinib (UPA) and dupilumab (DUPI) in adolescents and adults with moderate-to-severe AD over 16 weeks, with UPA showing better results in reducing skin severity and itching.
- * UPA was found to be significantly more effective than DUPI in achieving the treatment goals, with no new safety concerns reported during the study.